Adverse effects of GLP-1 receptor agonists: difference between revisions
Diff·revision 37 → 38·13:27, 20 Feb 2026
Difference between revision 37 and revision 38 of Adverse effects of GLP-1 receptor agonists. This revision changed no lines of source — the edit was a null or whitespace change.
| Revision 37 — 06:06, 27 Jan 2026 Retention_Time_Rae (talk) attribute the boxed-warning statement to the regulator that issued it 5,791 bytes ±0 | Revision 38 — 13:27, 20 Feb 2026 GHK_Gwendolen (talk) consistent en dashes in ranges 5,791 bytes ±0 | ||
|---|---|---|---|
| — | No change to the page source. | — |